Skip to main content
Top
Published in: Journal of Neural Transmission 11/2015

01-11-2015 | Neurology and Preclinical Neurological Studies - Original Article

Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait

Authors: Marina Picillo, Raffaele Dubbioso, Rosa Iodice, Alessandro Iavarone, Chiara Pisciotta, Emanuele Spina, Lucio Santoro, Paolo Barone, Marianna Amboni, Fiore Manganelli

Published in: Journal of Neural Transmission | Issue 11/2015

Login to get access

Abstract

Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson’s disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG−). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG−. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG− had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG−. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.
Literature
go back to reference Amboni M, Cozzolino A, Longo K, Picillo M, Barone P (2008) Freezing of Gait and executive function in Parkinson’s disease. Mov Disord 23:395–400CrossRefPubMed Amboni M, Cozzolino A, Longo K, Picillo M, Barone P (2008) Freezing of Gait and executive function in Parkinson’s disease. Mov Disord 23:395–400CrossRefPubMed
go back to reference Amboni M, Barone P, Picillo M, Cozzolino A, Longo K, Erro R et al (2010) A two-year follow up study of executive functions in parkinsonian patients at on state. Mov Disord 25:800–802CrossRefPubMed Amboni M, Barone P, Picillo M, Cozzolino A, Longo K, Erro R et al (2010) A two-year follow up study of executive functions in parkinsonian patients at on state. Mov Disord 25:800–802CrossRefPubMed
go back to reference Benarroch EE (2013) Pedunculopontine nucleus: functional organization and clinical implications. Neurology 80:1148–1155CrossRefPubMed Benarroch EE (2013) Pedunculopontine nucleus: functional organization and clinical implications. Neurology 80:1148–1155CrossRefPubMed
go back to reference Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM et al (2014) Extra-nigral pathological conditions are common in Parkinson’s disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord 29:1118–1124PubMedCentralCrossRefPubMed Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM et al (2014) Extra-nigral pathological conditions are common in Parkinson’s disease with freezing of gait: an in vivo positron emission tomography study. Mov Disord 29:1118–1124PubMedCentralCrossRefPubMed
go back to reference Celebi O, Temucin CM, Elibol B, Saka E (2012) Short latency afferent inhibition in Parkinson’s disease patients with dementia. Mov Disord 27:1052–1055CrossRefPubMed Celebi O, Temucin CM, Elibol B, Saka E (2012) Short latency afferent inhibition in Parkinson’s disease patients with dementia. Mov Disord 27:1052–1055CrossRefPubMed
go back to reference Devos D, Defebvre L, Bordet R (2010) Dopaminergic and nondopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundam Clin Pharmacol 24:407–421CrossRefPubMed Devos D, Defebvre L, Bordet R (2010) Dopaminergic and nondopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundam Clin Pharmacol 24:407–421CrossRefPubMed
go back to reference Di Lazzaro V, Oliviero A, Tonali P, Marra C, Daniele A, Profice P et al (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 13:392–397CrossRef Di Lazzaro V, Oliviero A, Tonali P, Marra C, Daniele A, Profice P et al (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 13:392–397CrossRef
go back to reference Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Bentivoglio AR et al (2004) Normal or enhanced short-latency afferent inhibition in Parkinson’s disease? Brain 127:E8CrossRefPubMed Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Bentivoglio AR et al (2004) Normal or enhanced short-latency afferent inhibition in Parkinson’s disease? Brain 127:E8CrossRefPubMed
go back to reference Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R et al (2005) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668PubMedCentralCrossRefPubMed Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R et al (2005) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668PubMedCentralCrossRefPubMed
go back to reference Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C et al (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111–1113CrossRefPubMed Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C et al (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111–1113CrossRefPubMed
go back to reference Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed
go back to reference Floresco SB, Magyar O (2006) Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology 188:567–585CrossRefPubMed Floresco SB, Magyar O (2006) Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology 188:567–585CrossRefPubMed
go back to reference Giladi N, Nieuwboer A (2008) Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 23:S423–S425CrossRefPubMed Giladi N, Nieuwboer A (2008) Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 23:S423–S425CrossRefPubMed
go back to reference Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170CrossRefPubMed Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170CrossRefPubMed
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
go back to reference Karachi C, Grabli D, Bernard FA, Tandé D, Wattiez N, Belaid H et al (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120:2745–2754PubMedCentralCrossRefPubMed Karachi C, Grabli D, Bernard FA, Tandé D, Wattiez N, Belaid H et al (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120:2745–2754PubMedCentralCrossRefPubMed
go back to reference Kessler KR, Ruge D, Ilić TV, Ziemann U (2005) Short latency afferent inhibition and facilitation in patients with writer’s cramp. Mov Disord 20:238–242CrossRefPubMed Kessler KR, Ruge D, Ilić TV, Ziemann U (2005) Short latency afferent inhibition and facilitation in patients with writer’s cramp. Mov Disord 20:238–242CrossRefPubMed
go back to reference Litvan I, Goldman J, Troster A, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356PubMedCentralCrossRefPubMed Litvan I, Goldman J, Troster A, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356PubMedCentralCrossRefPubMed
go back to reference Manganelli F, Vitale C, Santangelo G, Pisciotta C, Iodice R, Cozzolino A et al (2009) Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson’s disease. Brain 132:2350–2355PubMedCentralCrossRefPubMed Manganelli F, Vitale C, Santangelo G, Pisciotta C, Iodice R, Cozzolino A et al (2009) Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson’s disease. Brain 132:2350–2355PubMedCentralCrossRefPubMed
go back to reference Naismith SL, Shine JM, Lewis SJ (2010) The specific contributions of set-shifting to freezing of gait in Parkinson’s disease. Mov Disord 25:1000–1004CrossRefPubMed Naismith SL, Shine JM, Lewis SJ (2010) The specific contributions of set-shifting to freezing of gait in Parkinson’s disease. Mov Disord 25:1000–1004CrossRefPubMed
go back to reference Nardone R, Bergmann J, Brigo F, Christova M, Kunz A, Seidl M et al (2013) Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study. J Neural Transm 120:413–422CrossRefPubMed Nardone R, Bergmann J, Brigo F, Christova M, Kunz A, Seidl M et al (2013) Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study. J Neural Transm 120:413–422CrossRefPubMed
go back to reference Nardone R, Höller Y, Thomschewski A, Kunz AB, Lochner P, Golaszewski S et al (2014) Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL. J Neural Transm 121:1313–1320CrossRefPubMed Nardone R, Höller Y, Thomschewski A, Kunz AB, Lochner P, Golaszewski S et al (2014) Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL. J Neural Transm 121:1313–1320CrossRefPubMed
go back to reference Nieuwboer A, Giladi N (2013) Characterizing freezing of gait in Parkinson’s disease: models of an episodic phenomenon. Mov Disord 28:1509–1519CrossRefPubMed Nieuwboer A, Giladi N (2013) Characterizing freezing of gait in Parkinson’s disease: models of an episodic phenomenon. Mov Disord 28:1509–1519CrossRefPubMed
go back to reference Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A (2011) Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 10:734–744CrossRefPubMed Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A (2011) Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 10:734–744CrossRefPubMed
go back to reference Oliviero A, León AM, Holler I, Vila JF, Siebner HR, Della Marca G et al (2005) Reduced sensorimotor inhibition in the ipsilesional motor cortex in a patient with chronic stroke of the paramedian thalamus. Clin Neurophysiol 116:2592–2598CrossRefPubMed Oliviero A, León AM, Holler I, Vila JF, Siebner HR, Della Marca G et al (2005) Reduced sensorimotor inhibition in the ipsilesional motor cortex in a patient with chronic stroke of the paramedian thalamus. Clin Neurophysiol 116:2592–2598CrossRefPubMed
go back to reference Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123:1767–1783CrossRefPubMed Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123:1767–1783CrossRefPubMed
go back to reference Richardson SP, Bliem B, Lomarev M, Shamim E, Dang N, Hallett M (2008) Changes in short afferent inhibition during phasic movement in focal dystonia. Muscle Nerve 37:358–363CrossRefPubMed Richardson SP, Bliem B, Lomarev M, Shamim E, Dang N, Hallett M (2008) Changes in short afferent inhibition during phasic movement in focal dystonia. Muscle Nerve 37:358–363CrossRefPubMed
go back to reference Rizzo V, Aricò I, Liotta G, Ricciardi L, Mastroeni C, Morgante F et al (2010) Impairment of sensory-motor integration in patients affected by RLS. J Neurol 257:1979–1985CrossRefPubMed Rizzo V, Aricò I, Liotta G, Ricciardi L, Mastroeni C, Morgante F et al (2010) Impairment of sensory-motor integration in patients affected by RLS. J Neurol 257:1979–1985CrossRefPubMed
go back to reference Rochester L, Yarnall AJ, Baker MR et al (2012) Cholinergic dysfunction contributes to gait disturbances in early Parkinson’s disease. Brain 135:2779–2788PubMedCentralCrossRefPubMed Rochester L, Yarnall AJ, Baker MR et al (2012) Cholinergic dysfunction contributes to gait disturbances in early Parkinson’s disease. Brain 135:2779–2788PubMedCentralCrossRefPubMed
go back to reference Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003) Short and long latency afferent inhibition in Parkinson’s disease. Brain 126:1883–1894CrossRefPubMed Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003) Short and long latency afferent inhibition in Parkinson’s disease. Brain 126:1883–1894CrossRefPubMed
go back to reference Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E et al (2007) Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology 68:356–363CrossRefPubMed Sailer A, Cunic DI, Paradiso GO, Gunraj CA, Wagle-Shukla A, Moro E et al (2007) Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease. Neurology 68:356–363CrossRefPubMed
go back to reference Snijders AH, Leunissen I, Bakker M, Cook R, Silberstein P, Silburn PA et al (2011) Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain 134:59–72CrossRefPubMed Snijders AH, Leunissen I, Bakker M, Cook R, Silberstein P, Silburn PA et al (2011) Gait-related cerebral alterations in patients with Parkinson’s disease with freezing of gait. Brain 134:59–72CrossRefPubMed
go back to reference Tattersall TL, Stratton PG, Coyne TJ et al (2014) Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat Neurosci 17:449–454CrossRefPubMed Tattersall TL, Stratton PG, Coyne TJ et al (2014) Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat Neurosci 17:449–454CrossRefPubMed
go back to reference Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821–827CrossRefPubMed Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821–827CrossRefPubMed
go back to reference Tessitore A, Amboni M, Esposito F, Russo A, Picillo M, Marcuccio L et al (2012) Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord 18:781–787CrossRefPubMed Tessitore A, Amboni M, Esposito F, Russo A, Picillo M, Marcuccio L et al (2012) Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord 18:781–787CrossRefPubMed
go back to reference Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A et al (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523:503–513PubMedCentralCrossRefPubMed Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A et al (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523:503–513PubMedCentralCrossRefPubMed
go back to reference Yarnall A, Rochester L, Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson’s disease. Mov Disord 26:2496–2503CrossRefPubMed Yarnall A, Rochester L, Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson’s disease. Mov Disord 26:2496–2503CrossRefPubMed
go back to reference Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW et al (2013) Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson’s disease? Mov Disord 28:1285–1288CrossRefPubMed Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW et al (2013) Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson’s disease? Mov Disord 28:1285–1288CrossRefPubMed
Metadata
Title
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait
Authors
Marina Picillo
Raffaele Dubbioso
Rosa Iodice
Alessandro Iavarone
Chiara Pisciotta
Emanuele Spina
Lucio Santoro
Paolo Barone
Marianna Amboni
Fiore Manganelli
Publication date
01-11-2015
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 11/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-015-1428-y

Other articles of this Issue 11/2015

Journal of Neural Transmission 11/2015 Go to the issue

Neurology and Preclinical Neurological Studies - Original Article

Early Parkinson’s disease patients on rasagiline present with better odor discrimination